NCT05299996

Brief Summary

The urotheliasis is a common problem encountered daily by all urologists worldwide with rates up to 13% in North America, 9% in Europe and 5% in Asia . The urotheliasis is treated by conservation, medical treatment and surgery according to many factors . Anomalies in the kidney happens due to failure in ascending , fusion, rotation or all together, horse-shoe kidney is the most common example , found in one of 400 patients . PCNL and URS are the golden standard method for stone extraction worldwide, since their introduction 1975 by Fernstrom and Johansson \& Arthur Smith respectively in normal kidney .Since the development of the endourological procedures and instrument , continuous updates and upgrades have been applied ,such as enhancing the optical systems ,reducing the diameter, navigation (deflection angles) and stone fragmentation .Stone treatment in anomalous kidney is more demanding, requires more skills and training . The flexible ureterorenoscopy has some problems first the cost but this problem is being now solved by the use of disposable scopes , second the skills it requires , third the possibility of sepsis is higher . To our knowledge most of the studies in the literature are retrospective, carrying some weakness in them. There is no agreed-upon therapeutic method for treatment of stones in anomalous kidney so the investigators will evaluate the role of F-URS in a prospective study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 29, 2022

Completed
17 days until next milestone

Study Start

First participant enrolled

April 15, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

March 29, 2022

Status Verified

February 1, 2022

Enrollment Period

11 months

First QC Date

February 22, 2022

Last Update Submit

March 18, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • stone free rate post-operative

    CT will be done to evaluate the presence or absence of stone

    1 month after treatment

  • Change from Baseline hematocrit after 1 day postoperative

    bleeding due to any error either surgical or non surgical

    1 day after treatment

  • time of operation

    the operation will be recorded.

    during the operation

Study Arms (1)

all patients having stones in the upper tract of anomalous kidney

EXPERIMENTAL

patients having stones in abnormal anatomy , example horse-shoe kidney ,malrotation, crossed fusion , duplex collecting system. The stone size is 1 cm to 2.5 cm or 3.5 cm with variable density , located in calyx or the pelvis , single or multiple. the patient complain may be abdominal pain , loin pain, uremic symptoms .ct-kub non contrast , full lab \& fitness before the operation.

Procedure: flexible ureterorenoscopy

Interventions

stone disintegration stricture dilation tumor resection access guidance

all patients having stones in the upper tract of anomalous kidney

Eligibility Criteria

Age15 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Males and females age above 15 years.
  • Renal and ureteric stones either single or multiple wherever the site and site.
  • Pelvi-uretreic junction obstruction
  • Previous stented ureter.
  • Poorly functioning kidney.
  • Single functioning kidney.
  • Chronic kidney disease patient not on dialysis.
  • Previous operation in this kidney.
  • failed ESWL.

You may not qualify if:

  • Not fit for surgery.
  • Uncontrolled bleeding diathesis.
  • Untreated preoperative urinary tract infection (UTI).
  • non function kidney
  • skeletal abnormality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assuit Medical School

Asyut, Assuit, 71621, Egypt

Location

Related Publications (6)

  • Emiliani E, Traxer O. Single use and disposable flexible ureteroscopes. Curr Opin Urol. 2017 Mar;27(2):176-181. doi: 10.1097/MOU.0000000000000371.

    PMID: 28027075BACKGROUND
  • Singh AG, Chhabra JS, Sabnis R, Ganpule A, Jairath A, Shah D, Desai M. Role of flexible uretero-renoscopy in management of renal calculi in anomalous kidneys: single-center experience. World J Urol. 2017 Feb;35(2):319-324. doi: 10.1007/s00345-016-1881-8. Epub 2016 Jun 15.

    PMID: 27306685BACKGROUND
  • Giusti G, Proietti S, Peschechera R, Taverna G, Sortino G, Cindolo L, Graziotti P. Sky is no limit for ureteroscopy: extending the indications and special circumstances. World J Urol. 2015 Feb;33(2):257-73. doi: 10.1007/s00345-014-1345-y. Epub 2014 Jun 25.

    PMID: 24962930BACKGROUND
  • Patel SR, Nakada SY. The modern history and evolution of percutaneous nephrolithotomy. J Endourol. 2015 Feb;29(2):153-7. doi: 10.1089/end.2014.0287. Epub 2014 Sep 17.

    PMID: 25093997BACKGROUND
  • Lavan L, Herrmann T, Netsch C, Becker B, Somani BK. Outcomes of ureteroscopy for stone disease in anomalous kidneys: a systematic review. World J Urol. 2020 May;38(5):1135-1146. doi: 10.1007/s00345-019-02810-x. Epub 2019 May 17.

    PMID: 31101967BACKGROUND
  • Alelign T, Petros B. Kidney Stone Disease: An Update on Current Concepts. Adv Urol. 2018 Feb 4;2018:3068365. doi: 10.1155/2018/3068365. eCollection 2018.

    PMID: 29515627BACKGROUND

MeSH Terms

Conditions

Kidney CalculiCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFused Kidney

Condition Hierarchy (Ancestors)

NephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisUrinary CalculiMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsUrogenital AbnormalitiesCongenital Abnormalities

Central Study Contacts

abdelrahman M abdelkader, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator , urologist , teaching assisstant

Study Record Dates

First Submitted

February 22, 2022

First Posted

March 29, 2022

Study Start

April 15, 2022

Primary Completion

March 1, 2023

Study Completion

March 1, 2023

Last Updated

March 29, 2022

Record last verified: 2022-02

Locations